MARKET RADAR
SENSEX     NIFTY      Refresh
You are here : MONEYCONTROL > MARKETS > SHARE PRICE > PHARMACEUTICALS > COMPANY INFO - ALEMBIC PHARMACEUTICALS

Alembic Pharmaceuticals

BSE: 533573 | NSE: APLLTD | ISIN: INE901L01018 | SECTOR: PHARMACEUTICALS
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
LIVE
BSE
May 23, 17:00
119.90
-4.40 (-3.54%)
VOLUME 59,852
AVERAGE VOLUME
5-Day 75,257
10-Day 98,709
30-Day 103,017
VOLUME SHOCKER
5-Day 75,257
10-Day 98,709
30-Day 103,017
Prev. Close
124.30
Open Price
121.30
Bid PRICE (QTY.)
120.00 (375)
Offer PRICE (Qty.)
0.00 (0)
Today’s Low/High 119.25 123.00
52 Wk Low/High 47.50 139.95
LIVE
NSE
May 23, 17:00
119.75
-4.00 (-3.23%)
VOLUME 121,467
AVERAGE VOLUME
5-Day 175,251
10-Day 184,631
30-Day 194,560
VOLUME SHOCKER
5-Day 175,251
10-Day 184,631
30-Day 194,560
Prev. Close
123.75
Open Price
122.90
Bid PRICE (QTY.)
119.75 (502)
Offer PRICE (Qty.)
0.00 (0)
Today’s Low/High 119.00 122.90
52 Wk Low/High 45.00 140.25
Action in Alembic Pharmaceuticals
MARKET CAP (Rs Cr)
2,260.31
*P/E
14.36
*BOOK VALUE (Rs)
27.49
DIV (%)
70.00%
Market Lot
1
INDUSTRY P/E
27.54
*EPS (TTM)
8.35
*P/C
11.74
*PRICE/BOOK
4.36
DIV YIELD.(%)
1.17%
FACE VALUE (Rs)
2.00
DELIVERABLES (%)
64.15 new
DELIVERY AVERAGES
3-Day 58.88%
5-Day 56.10%
8-Day 53.51%
* Based on standalone numbers
Track Alembic Pharma on the go with moneycontrol app
EXPAND ALL COLLAPSE ALL
Would you bet on Alembic Pharma today?
Test your strategy with virtual money on Moneybhai
Historic Prices & Simple Moving Averages
on
1 week  |  1 month  |  3 month  |  1 year  |  2 year
  1 Year Current %Gain / Loss
Open Price 48.50 121.30  
High Price 49.10 123.00  
Low Price 47.70 119.25  
Last Price 48.70 119.90 146.20
Volume 9,625 59,852 521.84
Simple Moving Averages
Days BSE NSE
30 119.63 119.67
50 114.17 114.24
150 85.89 85.95
200 81.75 81.80

Get Historical Stock Prices »

Click here to view the Open, High, Low, Close, Volume and Spread data for Alembic Pharma

News/Videos & Announcements
Stock Advice & Research Reports
News Across the Web
Financials
Income Statement
(In Rs Cr)
  (Mar '13)
Quarterly
(Mar '13)
Yearly
Net Sales 376.02 1491.63
Other Income 0.07 3.93
PBDIT 61.78 247.69
Net Profit 39.71 157.45

Annual Report

Download in PDF format 2012 |2011
Balance Sheet
(Mar '13)
(In Rs Cr)
Total Share Capital 37.70
Net Worth 360.86
Total Debt 234.32
Net Block 267.81
Investments 3.35
Net Current Assets 261.81
Total Assets 595.16
Peers
Peer Comparison
Company Name Last Price %
Change
52 wk
High
52 wk
Low
Market Cap
Sun Pharma 1006.55 0.46 1016.70 569.00 104,236.50
Dr Reddys Labs 2051.05 -0.27 2150.90 1555.00 34,834.31
Lupin 748.90 -2.55 810.80 519.00 33,523.54
Cipla 415.00 -0.06 435.00 305.00 33,321.24
GlaxoSmithKline 2279.50 0.09 2522.00 2005.00 19,308.05
More » 
Share Holding Pattern & Mutual Funds Holding
Share Holding Pattern in (%)
 Mar' 13Dec' 12Jun' 12Mar' 12
Promoter74.1374.1374.1374.13
FII7.527.196.997.12
DII1.320.570.630.74
Others17.0318.1118.2518.01
Total100.00100.00100.00100.00
Company Information
REGISTERED OFFICE
Address
Alembic Road ,
City
Vadodra
State
Gujarat
Pin Code
390003
Tel. No.
0265-2280550 0265-2280880
Fax No.
0265-2282506
REGISTRARS
Name
Link Intime India Pvt. Ltd.
Address
B-102 &103, Shangrila Complex, First Floor, Near Radhakrishna Char Rasta, Akota
City
Vadodra - 390020
State
Gujarat
Tel. No.
0265-2356573, 2356794, 2252875, 2250241
Fax No.
0265-2356791, 2250246
Internet
MANAGEMENT
Name
Designation
Chirayu R Amin
Chairman & Managing Director
Pranav N Parikh
Director
K G Ramanathan
Director
Paresh Saraiya
Director
Rajkumar Baheti
Dir-President & Com.Secretary
Message Board & Community
Quick Links for Alembic Pharmaceuticals
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.